森沙夫定 |
 |
| 臨床資料 |
|---|
| 其他名稱 | 4'-ethynylstavudine, festinavir |
|---|
| 法律規範狀態 |
|---|
| 法律規範 |
|
|---|
| 識別資訊 |
|---|
1-[(2R,5R)-5-ethynyl-5-(hydroxymethyl)-2H-furan-2-yl]-5-methylpyrimidine-2,4-dione
|
| CAS號 | 634907-30-5 |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| KEGG | |
|---|
| ChEMBL | |
|---|
| NIAID ChemDB | |
|---|
| CompTox Dashboard (EPA) | |
|---|
| ECHA InfoCard | 100.225.812  |
|---|
| 化學資訊 |
|---|
| 化學式 | C12H12N2O4 |
|---|
| 摩爾質量 | 248.24 g·mol−1 |
|---|
| 3D模型（JSmol） | |
|---|
CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@](O2)(CO)C#C
|
InChI=1S/C12H12N2O4/c1-3-12(7-15)5-4-9(18-12)14-6-8(2)10(16)13-11(14)17/h1,4-6,9,15H,7H2,2H3,(H,13,16,17)/t9-,12+/m1/s1 Key:OSYWBJSVKUFFSU-SKDRFNHKSA-N
|
森沙夫定（英語：Censavudine，開發代碼：BMS-986001，也稱為4'-乙炔基司他夫定，4'-ethynylstavudine）是一種含氮有機化合物，化學式為C12H12N2O4，由百時美施貴寶作為HIV抑制劑開發。[1][2]
參考文獻[編輯]
- ^ Wu VH, Smith RA, Masoum S, Raugi DN, Ba S, Seydi M, et al. MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture. Antimicrobial Agents and Chemotherapy. August 2017, 61 (8). PMC 5527656
. PMID 28559249. doi:10.1128/AAC.00744-17.
- ^ Gupta SK, McComsey GA, Lombaard J, Echevarría J, Orrell C, Avihingsanon A, et al. Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. The Lancet. HIV. January 2016, 3 (1): e13–22. PMID 26762988. doi:10.1016/S2352-3018(15)00231-3. hdl:1805/10552 .
